San Diego, CA, United States of America

Ryan Andrew Adams

This inventor holds 14 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 3 EPO patents, primarily in Aminoacyl tRNA Synthetases. Top assignee: Atyr Pharma, Inc.. Active years: 2013-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ryan Andrew Adams. Retrieved from https://idiyas.com/inventor/ryan-andrew-adams

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 14 

% Patents Active = 64.3

 

 

Average Co-Inventor Count = 6.6

ph-index = 5

Forward Citations = 147(Granted Patents)


Company Filing History:


Years Active: 2013-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Anti-NRP2 Antibodies
Therapeutic Compositions
Aminoacyl tRNA Synthetases
Inflammation Modulation
Aspartyl-tRNA Synthetases
Glycyl-tRNA Synthetases
Biological Activities
Fc Conjugates
Non-Canonical Activities
Compositions
Methods
14 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Ryan Andrew Adams

Introduction

Ryan Andrew Adams is a prominent inventor based in San Diego, California. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic compositions. With a total of 14 patents to his name, Adams has established himself as a key figure in his area of expertise.

Latest Patents

Among his latest patents are compositions comprising anti-NRP2 antibodies. These patents provide affinity matured and humanized antibodies and antigen-binding fragments that specifically bind to human neuropilin-2 (NRP2) polypeptides. They modulate binding interactions between human NRP2 and at least one NRP2 ligand, influencing subsequent NRP2-mediated downstream signaling events. These innovations include related therapeutic compositions and methods for modulating NRP2 activity, which can be crucial in treating NRP2-associated diseases.

Career Highlights

Ryan Andrew Adams is currently associated with Atyr Pharma, Inc., where he continues to push the boundaries of medical research and innovation. His work focuses on developing novel therapeutic strategies that can significantly impact patient care and treatment outcomes.

Collaborations

Adams collaborates with notable colleagues, including Leslie Ann Greene and Kristi Helen Piehl. Their combined expertise fosters a dynamic research environment that enhances the potential for groundbreaking discoveries.

Conclusion

Ryan Andrew Adams exemplifies the spirit of innovation in biotechnology through his extensive patent portfolio and collaborative efforts. His work not only advances scientific knowledge but also holds promise for improving therapeutic options for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…